Login / Signup

Nordic inflammatory bowel disease treatment strategy trial: protocol for the NORDTREAT randomised controlled biomarker-strategy trial.

Martin RejlerJohannes David FüchtbauerLóa G DavíðsdóttirAnja FejrskovJohan D SöderholmRobin ChristensenVibeke AndersenDirk RepsilberJens KjeldsenMarte HøivikJonas Halfvarson
Published in: BMJ open (2024)
NCT05180175; Pre-results. EudraCT number: 2019-002942-19.
Keyphrases
  • study protocol
  • phase iii
  • randomized controlled trial
  • phase ii
  • clinical trial
  • open label
  • combination therapy